Recent research suggests that GLP-1 drugs, known for their weight loss and diabetes management, can also be a valuable tool for treating people with alcohol use disorder (AUD). Recent studies have discovered that these medications, containing the ingredients semaglutide or tirzepatide, also known as Mounjaro or Zepbound, seem to reduce hospitalizations related to alcohol use
Two significant surveys are revealing historic highs in the use of hallucinogens and cannabis among adults. In 2023, the Monitoring the Future survey showed that past-year use of cannabis and hallucinogens remained at historically high levels among adults aged 19 to 30 and 35 to 50. Another, more recent study by the University of Michigan’s
People who drink regularly also tend to have other behavioral issues. Scientists have found genetics related to regular drinking and other addictive behaviors. They found that people who drink are more likely to have addictions to social media, internet use, gaming, exercise, gambling, hair pulling, or eating. They believe that people who share these issues
Medication-Assisted Treatment, also known as MAT, is considered the gold standard for opioid use disorder treatment. Less known is that effective and safe medication is available for Alcohol Use Disorder. The research followed three medications for AUD: acamprosate, disulfiram, and naltrexone. All patients observed in the study were using these drugs, which showed it lowered
